Directors' Shareholdings / Issue of Equity

RNS Number : 1870F

Deltex Medical Group PLC

19 April 2011

 



 

 

Deltex Medical Group plc

Directors' Shareholdings/Issue of equity

19 April 2011 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has today issued a total of 83,165 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 28.50 pence per share.

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 January 2011 to 31 March 2011.

Paul Mitchell has elected to take New Ordinary Shares in lieu of £2,704 of salary after tax in respect of the period 1 January 2011 to 31 March 2011.

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 27 April 2011.  Following the issue of these new shares the Company has a total of 137,915,058 ordinary shares of 1p each in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of New Ordinary Shares issued in lieu of fees/salary	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	29,239	5,663,043	4.11
Dr Edwin Snape	21,053	1,046,773	0.76
Sir Duncan Nichol	10,526	612,633	0.44
Julian Cazalet	16,842	3,472,230	2.52
Paul Mitchell	5,505	136,036	0.10

For further information, please contact:-

Deltex Medical Group plc                                                                                01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                                        0207 614 5917

Arden Partners plc 

Christopher Hardie

Jamie Cameron

 

END

 

 

IOEILMTTMBTBBMB